Drug Testing Locations - Arapahoe, CO

Drug Testing in Arapahoe, CO

Arapahoe, Colorado Statistics

In 2022, Arapahoe County recorded a 25% increase in opioid-related hospitalizations.

Arapahoe County's 2021 overdose death rate was 45 per 100,000 residents.

Methamphetamine incidents in Arapahoe County rose by 30% in 2021 compared to 2020.

Teen drug use in Arapahoe County decreased by 15% between 2019 and 2021.

Heroin-related arrests in Arapahoe County increased by 20% in 2021.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Arapahoe, CO & Drug Testing Policies

In Arapahoe County, employers are proactive in ensuring a drug-free workplace environment. Many companies have implemented policies consistent with the guidelines from the U.S. Department of Labor. These measures include pre-employment and random drug testing, with employment offers contingent on passing such tests.

Organizations collaborate with local health departments to conduct awareness workshops about substance abuse. The goal is not only to maintain productivity but also to ensure a safe working environment. Employers advocate for health and wellness programs that offer support to employees dealing with addiction.

Government Efforts with Drug Problems in Arapahoe, CO

In response to rising drug issues, Arapahoe County has intensified its efforts with support from both local and state authorities. The Arapahoe County Government collaborates with Colorado Department of Human Services to provide prevention programs and increase public awareness on drug abuse.

The county also partners with the Substance Abuse and Mental Health Services Administration to secure funding for treatment facilities, focusing on reducing the opioid crisis impact. Initiatives include educational campaigns and training first responders in the use of naloxone, an opioid overdose reversal drug.

Local Drug Busts & News in Arapahoe, CO

Arapahoe County has witnessed several significant drug-related events. In a major operation in 2023, local law enforcement agencies dismantled a drug trafficking ring, seizing large quantities of fentanyl and methamphetamines. This operation highlighted the collaboration between city police and federal agencies, including the Drug Enforcement Administration.

Community rallies and forums are often organized throughout Arapahoe to raise awareness and discuss preventive strategies. These events are a testament to the community's commitment to combating drug abuse, bringing together law enforcement, public health officials, and the general populace.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Arapahoe, CO. Trusted by employers nationwide for accurate results and exceptional service.

Colorado DOT/Non DOT Physicals

Colorado Vision Tests

Colorado Audiograms

Colorado Respirator Fit Tests

Colorado Lift Tests

Colorado Background Checks

Clinical Testing Services

TB Testing in CO

Diabetes Testing in CO

Infectious Disease Testing in CO

Sickle Cell Anemia Testing in CO

Women/Men's Health Testing in CO

Resources & Citations

Colorado Crisis Services

Signal Behavioral Health Network

Therapist Locator - Colorado

Denver Health Behavioral Health Services

CDC on Colorado Drug Overdose

SAMHSA National Helpline

Intervention Services Colorado Rehab Centers

OMNI Institute Colorado

Drug Testing Near Arapahoe, CO

Agate, CO

Foxfield, CO

Elizabeth, CO

Parker, CO

Ponderosa Park, CO

Aetna Estates, CO

Deer Trail, CO

Watkins, CO

East Adams, CO

Peoria, CO

Bennett, CO

Byers, CO

Strasburg, CO

East Arapahoe, CO

Comanche Creek, CO

Frequently Asked Questions

Customer Reviews